Work

Dupilumab improves type 2 comorbidity outcomes in patients with eosinophilic esophagitis and comorbid disease at baseline: from Parts A and B of LIBERTY-EoE-TREET

Year: 2023

Type: article

Source: Journal of Allergy and Clinical Immunology

DOI: 10.1016/j.jaci.2022.12.622

Authors: Jonathan Spergel, Lawrence Sher, Sandy Durrani, Evan Dellon, Marc Rothenberg, Xian Sun, Bethany Beazley, Kiran Patel, Arsalan Shabbir

Institutions: Children's Hospital of Philadelphia, Cincinnati Children's Hospital Medical Center, University of Cincinnati, University of North Carolina at Chapel Hill, Regeneron (United States), Sanofi (United States)

Language: English

Topic: Eosinophilic Esophagitis

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4319082392

FWCI: 0.505

Cites:

Cited by: 2

Related to: 10